Doctor profile · Federal record

Dr. Mark Sloane, M.D.

Critical Care Medicine (Internal Medicine) Physician (CMS: Critical Care (Intensivists)) · Pulmonary Disease Physician · New York, NY

  • NPI 1801852637
  • Accepts Medicare
  • MIPS 84.5 / 100 · 2023
  • 41 yrs in practice
  • Male
  • Solo practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
436 3Rd Ave, Second Floor
New York, NY 100166025
(212) 685-6660
fax (212) 481-7224

Credentials & registration

NPPES · NUCC
NPI registered
April 2006 — 20 yrs on file
Profile last updated
March 7, 2023
Year of graduation
1985 — 41 yrs since
Specialty taxonomy
207RC0200X — NUCC code
State license (1)
New York #169212

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1801852637. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
1,316
Distinct HCPCS
10
Medicare allowed
$130,870
HCPCS Description Services Patients Avg allowed
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg 282 81 $0
99215 Established patient office or other outpatient visit, 40-54 minutes 279 141 $205
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes 192 103 $135
94726 Test to determine lung volumes using sensors 138 106 $64
94729 Test to examine how well the lungs exchange gases 137 105 $67
94060 Test to measure expiratory airflow and volume changes before and after medication administration 125 98 $46
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes 42 41 $197
99214 Established patient office or other outpatient visit, 30-39 minutes 39 34 $145
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes 33 30 $90
99205 New patient office or other outpatient visit, 60-74 minutes 24 24 $254

In context: peer comparison

Among 45 peers in New York Critical Care Medicine (Internal Medicine) Physician, average services per provider: 82. This provider delivers 16× the peer median.

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,126
Patients
229
Total drug cost
$327,478
Drug Type Claims Patients Total cost
Montelukast Sodium Generic 289 77 $4,736
Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) Brand 140 23 $122,110
Albuterol Sulfate Hfa (Albuterol Sulfate) Brand 135 49 $6,531
Prednisone Generic 118 43 $1,143
Breo Ellipta (Fluticasone/Vilanterol) Brand 103 24 $66,840
Symbicort (Budesonide/Formoterol Fumarate) Brand 58 0 $27,992
Spiriva Respimat (Tiotropium Bromide) Brand 39 0 $29,883
Incruse Ellipta (Umeclidinium Bromide) Brand 37 0 $15,019
Roflumilast Generic 36 0 $6,445
Advair Diskus (Fluticasone Propion/Salmeterol) Brand 35 0 $24,243

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Mark Sloane's medical specialty?
Dr. Mark Sloane practices Critical Care Medicine (Internal Medicine) Physician in New York, NY.
Where does Dr. Mark Sloane practice?
Dr. Mark Sloane practices at 436 3Rd Ave, New York, NY 100166025. Office phone: 2126856660.
What is Dr. Mark Sloane's NPI?
Dr. Mark Sloane's National Provider Identifier (NPI) is 1801852637, issued by NPPES.
Does Dr. Mark Sloane accept Medicare assignment?
Yes. Dr. Mark Sloane accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Mark Sloane commonly perform?
Top Medicare-reported procedures in 2023: Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg (HCPCS J7613); Established patient office or other outpatient visit (HCPCS 99215); Subsequent hospital care with moderate levelof medical decision making (HCPCS 99233). Source: CMS Medicare Physician & Other Practitioners file.